Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Yves, Berthiaume"'
Autor:
Ariane Quintal, Isabelle Carreau, Annie-Danielle Grenier, Caroline Hébert, Christine Yergeau, Yves Berthiaume, Eric Racine
Publikováno v:
Journal of Participatory Medicine, Vol 15, p e46607 (2023)
BackgroundOwing to their low prevalence, rare diseases are poorly addressed in the scientific literature and clinical practice guidelines. Thus, health care workers are inadequately equipped to provide timely diagnoses, appropriate treatment, and sup
Externí odkaz:
https://doaj.org/article/69810e984ad4421b9d9a66ffb3c40ce2
Autor:
Jiafen Gong, Gengming He, Cheng Wang, Claire Bartlett, Naim Panjwani, Scott Mastromatteo, Fan Lin, Katherine Keenan, Julie Avolio, Anat Halevy, Michelle Shaw, Mohsen Esmaeili, Guillaume Côté-Maurais, Damien Adam, Stéphanie Bégin, Candice Bjornson, Mark Chilvers, Joe Reisman, April Price, Michael Parkins, Richard van Wylick, Yves Berthiaume, Lara Bilodeau, Dimas Mateos-Corral, Daniel Hughes, Mary J. Smith, Nancy Morrison, Janna Brusky, Elizabeth Tullis, Anne L. Stephenson, Bradley S. Quon, Pearce Wilcox, Winnie M. Leung, Melinda Solomon, Lei Sun, Emmanuelle Brochiero, Theo J. Moraes, Tanja Gonska, Felix Ratjen, Johanna M. Rommens, Lisa J. Strug
Publikováno v:
npj Genomic Medicine, Vol 7, Iss 1, Pp 1-15 (2022)
Abstract Over 400 variants in the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) are CF-causing. CFTR modulators target variants to improve lung function, but marked variability in response exists and current therapies do not address
Externí odkaz:
https://doaj.org/article/c9a883e6061748a2ad1bb0acfad420a2
Autor:
Francis Migneault, Frédéric Gagnon, Mihai Pascariu, Jonathan Laperle, Antoine Roy, André Dagenais, Yves Berthiaume
Publikováno v:
Cellular Physiology and Biochemistry, Vol 52, Iss 5, Pp 984-1002 (2019)
Externí odkaz:
https://doaj.org/article/9f45e255448a487991604b30b9ed703d
Autor:
Quitterie Reynaud, Valérie Boudreau, Sandrine Touzet, Katherine Desjardins, Stéphanie Poupon Bourdy, Emilie Blond, Yves Berthiaume, Rémi Rabasa-Lhoret, Isabelle Durieu
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Cystic fibrosis (CF)-related diabetes is associated with increased mortality. We analysed the clinical and glycemic profiles of two cohorts of patients treated according to the same guidelines in France and Canada. To investigate incidence d
Externí odkaz:
https://doaj.org/article/ea68f3c1206447ae808634324d5b1e4c
Autor:
Philippe Joly, John C. Marshall, Philippe A. Tessier, Chantal Massé, Nathalie Page, Anne Julie Frenette, François Khazoom, Soazig Le Guillan, Yves Berthiaume, Emmanuel Charbonney
Publikováno v:
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 25, Iss 1, Pp 1-6 (2017)
Abstract Background Following tissue injury after trauma, the activation of innate immune pathways results in systemic inflammation, organ failure and an increased risk of infections. The objective of this study was to characterize the kinetics of th
Externí odkaz:
https://doaj.org/article/2992aa0d43f34c97a9f6933a45f2599f
Autor:
Mélissa Aubin Vega, Cécile Chupin, Mihai Pascariu, Anik Privé, André Dagenais, Yves Berthiaume, Emmanuelle Brochiero
Publikováno v:
Physiological Reports, Vol 7, Iss 21, Pp n/a-n/a (2019)
Abstract Acute respiratory distress syndrome (ARDS) features an exudative phase characterized by alveolar damage, lung edema and exacerbated inflammatory response. Given their anti‐inflammatory properties, the potential therapeutic effect of cortic
Externí odkaz:
https://doaj.org/article/9ca371ac4730415ca53e4caf131588c0
Autor:
Rudolf Lucas, Yalda Hadizamani, Joyce Gonzales, Boris Gorshkov, Thomas Bodmer, Yves Berthiaume, Ueli Moehrlen, Hartmut Lode, Hanno Huwer, Martina Hudel, Mobarak Abu Mraheil, Haroldo Alfredo Flores Toque, Trinad Chakraborty, Jürg Hamacher
Publikováno v:
Toxins, Vol 12, Iss 4, p 223 (2020)
Bacterial toxins play a key role in the pathogenesis of lung disease. Based on their structural and functional properties, they employ various strategies to modulate lung barrier function and to impair host defense in order to promote infection. Alth
Externí odkaz:
https://doaj.org/article/2de2234a97f541b9945af7f13ab1d273
Autor:
Sébastien Préville-Ratelle, Adèle Coriati, Aurélie Ménard, Isabelle Bourdeau, François Tremblay, Yves Berthiaume
Publikováno v:
Canadian Respiratory Journal, Vol 2018 (2018)
Background. The prevalence of adrenal insufficiency (AI) in cystic fibrosis (CF) is unknown. The frequent use of glucocorticoids (inhaled or systemic) may induce the long-term suppression of the hypothalamic-pituitary-adrenal axis. Methods. We review
Externí odkaz:
https://doaj.org/article/2a03a33fe7864af88ecce7da6be74763
Publikováno v:
Journal of Cystic Fibrosis. 20:e93-e99
YKL-40 (chitinase 3-like 1 gene; CHI3L1) is an inflammatory marker that is increased in the blood of patients with inflammatory diseases, including cystic fibrosis (CF). The objective of our study was to explore the relationship between circulating l
Autor:
Emmanuelle Brochiero, Pearce G. Wilcox, Lara Bilodeau, Mays Merjaneh, Nancy Morrison, Lisa J. Strug, Angela Hillaby, Julie Avolio, Katherine Keenan, Lynda Lazosky, Jennifer Itterman, Michael D. Parkins, Émilie Maille, Naim Panjwani, Mark A. Chilvers, Lei Sun, Jennifer Pike, Richard van Wylick, Yu Chung Lin, Raquel Consunji-Araneta, Caroline Burgess, Lorna Kosteniuk, Lori Fairservice, Christine Donnelly, Natalie Henderson, Damien Adam, Scott M. Blackman, Dimas Mateos-Corral, Bradley S. Quon, Mary Jackson, Janna Brusky, Felix Ratjen, Elizabeth Tullis, Garry R. Cutting, Clare Smith, Melinda Solomon, Harriet Corvol, Valerie Levesque, Daniel Hughes, Fan Lin, Nathalie Vadeboncoeur, Candice Bjornson, Yves Berthiaume, Guillaume Côté-Maurais, Anne L. Stephenson, Winnie Leung, Shaikh Iqbal, Jiafen Gong, Johanna M. Rommens, Mary Jane Smith, Paula Barrett, Joe Reisman, Terry Viczko, Katie Griffin, Danny Veniott, Vanessa McMahon, Stéphanie Bégin, April Price, Emma Karlsen, Andrea Dale
Publikováno v:
Genetics in Medicine
Purpose Cystic fibrosis (CF), caused by pathogenic variants in the CF transmembrane conductance regulator (CFTR), affects multiple organs including the exocrine pancreas, which is a causal contributor to cystic fibrosis–related diabetes (CFRD). Unt